SEC 13F Intelligence

Managers / Q2 2024 · view latest →

HARBOURVEST PARTNERS LLC

CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707

Reported Value
$188M
Q2 2024
Positions
40
Filings on Record
32
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Harbourvest Partners LLC reported $188M in U.S.-listed holdings across 40 positions for Q2 2024.

The portfolio is heavily concentrated: TOST alone accounts for 31.3% of reported value.

Compared with Q1 2024, the fund opened 0 new positions and exited 8.

Portfolio Metrics

Turnover
+10.2%
vs prior filed quarter
Top-10 Concentration
+88.4%
share of reported value
Largest Position
+31.3%
Toast

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $211MQ4 ’18Q1 ’19: $283MQ2 ’19: $262MQ3 ’19: $240MQ4 ’19: $243MQ4 ’19Q1 ’20: $207MQ2 ’20: $232MQ3 ’20: $270MQ4 ’20: $256MQ4 ’20Q1 ’21: $746MQ2 ’21: $1.0BQ3 ’21: $1.1BQ4 ’21: $782MQ4 ’21Q1 ’22: $490MQ2 ’22: $305MQ3 ’22: $306MQ4 ’22: $299MQ4 ’22Q1 ’23: $297MQ2 ’23: $352MQ3 ’23: $295MQ4 ’23: $299MQ4 ’23Q1 ’24: $219MQ2 ’24: $188MQ3 ’24: $192MQ4 ’24: $203MQ4 ’24Q1 ’25: $154MQ2 ’25: $91MQ3 ’25: $205MQ4 ’25: $174MQ4 ’25Q1 ’26: $101Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.5%ADR: 5.5%Other: 4.0%
  • Common Stock · 90.5% · $170M
  • ADR · 5.5% · $10M
  • Other · 4.0% · $8M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
HashiCorp, Inc.ADDED+462.6K671.9K+$17M$23M
NABLN-Able, Inc.SOLD OUT−1.29M0−$17M$0
MNDYmonday.com Ltd.SOLD OUT−9.9K0−$2M$0
PATHUiPath, Inc.SOLD OUT−63.7K0−$1M$0
HOODRobinhood Markets Inc.SOLD OUT−50.7K0−$1M$0
TWLOTwilio, Inc.SOLD OUT−14.6K0−$891,078$0
PINSPinterest, Inc.SOLD OUT−21.3K0−$738,818$0
CPNGCoupang Inc.SOLD OUT−26.8K0−$477,377$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

40 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TOSTToast, Inc.history →Common CLA31.32%$59M2.28M
2WWayfair Inc.history →Common CLA29.81%$56M1.06M
3HashiCorp, Inc.Common CLA12.05%$23M671.9K
4YMMFull Truck Alliance Co. Ltd.history →Sponsored ADS4.10%$8M957.6K
5Omega Therapeutics, Inc.Common3.87%$7M3.51M
6LendingClub Corp.Common NEW2.31%$4M513.4K
7PGNYProgyny, Inc.history →Common1.37%$3M89.7K
8HSAIHesai Grouphistory →Sponsored ADS1.35%$3M606.1K
9IBRXImmunityBio, Inc.history →Common1.13%$2M335.7K
10BEBloom Energy Corporationhistory →Common CLA1.06%$2M162.2K
11ACVAACV Auctions, Inc.history →Common CLA1.05%$2M108.1K
12RLAYRelay Therapeutics, Inc.history →Common1.03%$2M296.4K
13Inari MedicalCommon0.99%$2M38.5K
14Zuora, Inc.Common CLA0.87%$2M163.9K
15DOCNDigitalOcean, Inc.Common0.82%$2M44.2K
16Olo, Inc.Common CLA0.80%$2M341.8K
17DOCSDoximity, Inc.Common CLA0.74%$1M49.8K
18HNSTHonest Company Inc.Common0.74%$1M475.6K
19AMPLAmplitude Inc.Common CLA0.72%$1M153.0K
20SONDQSonder Holdings, Inc.CL A NEW0.55%$1M225.1K
21DIBS1stdibs.com, Inc.Common0.48%$895,737199.5K
22IASIntegral Ad Science, Inc.Common0.47%$892,09291.8K
23COURCoursera, Inc.Common0.40%$759,762106.1K
24AFRMAffirm, Inc.Common CLA0.37%$701,17423.2K
25UUnity SoftwareCommon0.30%$555,99434.2K
26PLRXPliant Therapeutics, Inc.Common0.28%$531,41649.4K
27Eventbrite, Inc.Common CLA0.26%$494,474102.2K
28GTMZoomInfo Technologies IncCommon0.26%$494,11038.7K
29NeueHealth, Inc.Common NEW0.15%$286,79752.7K
30QSQuantumScape CorporationCommon CLA0.15%$277,97556.5K
31OPENOpendoor Technologies Inc.Common0.05%$85,94146.7K
32IPSCCentury Therapeutics, Inc.Common0.04%$73,99629.0K
33RPTXRepare Therapeutics, Inc.Common0.02%$40,51112.3K
34Seres Therapeutics, Inc.Common0.02%$35,72949.4K
35PACBPacific Biosciences of California, Inc.Common0.02%$32,17323.5K
36Rallybio Holdings, LLCCommon0.02%$29,31521.9K
37PMVPPMV PharmaceuticalsCommon0.01%$18,68311.5K
38NextCure, Inc.Common0.01%$15,97010.0K
39Aligos Therapeutics, Inc.Common0.00%$6,57418.8K
40Astra Space, Inc.CL A NEW0.00%$6,26312.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$101M5May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$174M7Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$205M9Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$91M15Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$154M16May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$203M22Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$192M34Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$188M40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$219M48May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$299M53Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$295M58Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$352M60Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$297M63May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$299M65Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$306M67Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$305M62Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$490M66May 26, 2022RESTATEMENTchanges · EDGAR ↗
Q4 2021$782M67Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.1B56Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.0B51Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$746M44May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$256M26Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$270M36Nov 12, 202013F-HRchanges · EDGAR ↗
Q2 2020$232M28Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$207M36May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$243M35Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$240M33Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$262M32Aug 13, 201913F-HRchanges · EDGAR ↗
Q1 2019$283M33May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$211M32Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.